Literature DB >> 8836405

Single cell analysis of Hodgkin/Reed-Sternberg cells.

R Küppers1, H Kanzler, M L Hansmann, K Rajewsky.   

Abstract

The origin and clonality of the Hodgkin and Reed-Sternberg (HRS) cells in Hodgkin's disease (HD) has been much debated. Recently, single cell PCR techniques were established, allowing the study of HRS cells at the single cell level. HRS cells were analysed for Ig gene rearrangements to reveal a potential origin from B lineage cells. Whereas one study did not detect any V gene rearrangements, such rearrangements were found in three other investigations. However, whereas our own group detected clonal V gene rearrangements in the HRS cells of 11 (10 classical and one lymphocyte predominant) out of 12 cases of HD and no rearrangements in the twelfth, Delabie et al. (Blood 1994; 84: 3291-8) described four cases of lymphocyte predominant HD with polyclonal V gene rearrangements and Hummel and colleagues detected monoclonal as well as polyclonal and "mixed' populations of HRS cells in cases of classical HD. Potential reasons for the differing results of those investigations are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8836405     DOI: 10.1093/annonc/7.suppl_4.s27

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  3 in total

1.  Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice.

Authors:  Silke H Raffegerst; Gabriele Hoelzlwimmer; Sandra Kunder; Josef Mysliwietz; Leticia Quintanilla-Martinez; Dolores J Schendel
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

Review 2.  Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma.

Authors:  Katerina Vrzalikova; Maha Ibrahim; Eszter Nagy; Martina Vockerodt; Tracey Perry; Wenbin Wei; Ciaran Woodman; Paul Murray
Journal:  Cancers (Basel)       Date:  2018-08-24       Impact factor: 6.639

Review 3.  Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases.

Authors:  Xinle Cui; Clifford M Snapper
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.